Comparison of the Toric Implantable Collamer Lens and Custom Ablation LASIK for Myopic Astigmatism
| Autor: | Monica L. Sanders, Donald R. Sanders |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Adult
Male medicine.medical_specialty Refractive error Visual acuity genetic structures medicine.medical_treatment Keratomileusis Laser In Situ Visual Acuity Keratomileusis Myopic astigmatism Optics Lens Implantation Intraocular Ophthalmology Myopia medicine Humans Dioptre Lenses Intraocular Implantable collamer lens business.industry Astigmatism LASIK medicine.disease Ablation eye diseases Treatment Outcome Female Lasers Excimer Surgery medicine.symptom business |
| Zdroj: | Journal of Refractive Surgery. 24:773-778 |
| ISSN: | 1081-597X |
| DOI: | 10.3928/1081597x-20081001-02 |
| Popis: | PURPOSETo compare the results of wavefront-guided custom LASIK and the Toric Implantable Collamer Lens (TICL) in the correction of myopic astigmatism. METHODSThis observational, non-randomized study compared clinical efficacy results from the TICL’s US Food and Drug Administration Clinical Trial and published Summaries of Safety and Effectiveness of two wavefront-guided lasers: STAR S4 CustomVue excimer laser system (VISX Inc) and LADARVision4000 CustomCornea excimer laser system (Alcon Laboratories Inc). Preoperative myopic refractive error was divided into two groups: –3.00 to –7.00 diopters (D) and –7.00 to –11.00 D. RESULTSThe percentage of eyes with uncorrected visual acuity (UCVA) of 20/20 and 20/40 and predictability of manifest refraction spherical equivalent within ±0.50 and ±1.00 D in the three groups was similar with only one statistically significant difference (TICL versus Alcon within ±1.00 D: 97% versus 82%; P=.008). The TICL had significantly better postoperative best spectacle-corrected visual acuity (BSCVA) compared to preoperative BSCVA than both the VISX CustomVue and Alcon CustomCornea (PP CONCLUSIONSAlthough comparable in clinical efficacy outcomes, the TICL had a significantly better postoperative improvement in BSCVA and significantly better postoperative UCVA than preoperative BSCVA. The TICL can be considered as an alternative to LASIK through the full range of use. [J Refract Surg. 2008;24:773-778.] ABOUT THE AUTHORS From the University of Illinois Eye and Ear Infirmary, Chicago (D.R. Sanders); and Center for Clinical Research, (D.R. Sanders, M.L. Sanders) Elmhurst, Ill. This study was funded by STAAR Surgical, Monrovia, Calif. Dr Sanders is a paid consultant to STAAR Surgical, Monrovia, Calif. Ms Sanders has no proprietary interest in the materials presented herein. Correspondence: Donald R. Sanders, MD, PhD, Center for Clinical Research, 242 N York Rd, Ste 102, Elmhurst, IL 60126. Tel: 630.530.9700; Fax: 630.530.1636; E-mail: drsmd@drsmd.com Received: March 20, 2007 Accepted: September 19, 2007 Posted online: March 15, 2008 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|